Search
Companies
Transforming special needs into big achievements - in urology, rheumatology, gynecology, neurology and other indications More
In-licensing
Therapeutic drugs in late stage development (marketed, registered or in clinical trials) are sought to complement our product portfolio. More
Out-licensing
No results found for given criteria.
Try to use our Advanced search for this category.
Reports
1st December 2009
The growing recognition from companies of the applied benefits from biomarkers in rheumatology has spurred commercial interest in this field. Despite the lack of major advancements, the hope remains that soon rheumatologists will be able to predict response to expensive biologic therapies and match specific treatments to patients based upon biomarker profiles. More
Price: $3,800.00
Price: $3,800.00
1st September 2008
1st December 2006
Use this Datamonitor report to benchmark late-stage pipeline products against the market leader More
Price: $15,200.00
Price: $15,200.00
1st September 2006
This report provides you with a breakdown of treatment trends in the following markets: US, Japan, France, Germany, Italy, Spain and the UK
More
Price: $15,200.00
Price: $15,200.00
1st June 2006
This report provides qualitative interviews with key opinion leaders including treating physicians, patient advocates and research scientists More
Price: $11,400.00
Price: $11,400.00
© Copyright 1998-2010 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us